AU2003270625A1 - Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing - Google Patents
Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healingInfo
- Publication number
- AU2003270625A1 AU2003270625A1 AU2003270625A AU2003270625A AU2003270625A1 AU 2003270625 A1 AU2003270625 A1 AU 2003270625A1 AU 2003270625 A AU2003270625 A AU 2003270625A AU 2003270625 A AU2003270625 A AU 2003270625A AU 2003270625 A1 AU2003270625 A1 AU 2003270625A1
- Authority
- AU
- Australia
- Prior art keywords
- adam15
- adam9
- vascularization
- inhibition
- activation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000004913 activation Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000029663 wound healing Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40985802P | 2002-09-11 | 2002-09-11 | |
US60/409858 | 2002-09-11 | ||
PCT/US2003/028751 WO2004024089A2 (en) | 2002-09-11 | 2003-09-11 | Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003270625A8 AU2003270625A8 (en) | 2004-04-30 |
AU2003270625A1 true AU2003270625A1 (en) | 2004-04-30 |
Family
ID=31994015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003270625A Abandoned AU2003270625A1 (en) | 2002-09-11 | 2003-09-11 | Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003270625A1 (en) |
WO (1) | WO2004024089A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7309487B2 (en) * | 2004-02-09 | 2007-12-18 | George Inana | Methods and compositions for detecting and treating retinal diseases |
NZ556561A (en) | 2005-02-02 | 2011-08-26 | Macrogenics West Inc | Adam-9 modulators |
WO2007083949A1 (en) * | 2006-01-19 | 2007-07-26 | Eyegene Inc. | Pharmaceutical composition for treating vascular-related diseases comprising peptide |
GB2453589A (en) | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
WO2009101968A1 (en) * | 2008-02-14 | 2009-08-20 | Gene Techno Science Co., Ltd. | Anti-adam-15 antibodies and utilization of the same |
EP2271668B1 (en) | 2008-03-24 | 2017-12-20 | Salman Rahman | Adam-15 antibodies and immunogenic peptides |
EP2398481A2 (en) * | 2009-02-19 | 2011-12-28 | Galapagos N.V. | Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
WO2012042391A2 (en) | 2010-10-01 | 2012-04-05 | Salman Rahman | Methods for the development of metzincin-selective catalytic cleft directed antibodies for therapeutic and diagnostic applications |
EP3700521B1 (en) | 2017-10-29 | 2024-06-12 | China Medical University | Use of adam9 inhibitor compound and composition including adam9 inhibitor compound |
TWI735210B (en) * | 2019-04-26 | 2021-08-01 | 中國醫藥大學 | Use of adam9 inhibitor as immune modulator |
CN114578052A (en) * | 2022-03-08 | 2022-06-03 | 新疆医科大学第一附属医院 | Application of ADAM10 in occlusive cardiovascular and cerebrovascular diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003525203A (en) * | 1999-03-22 | 2003-08-26 | ダーウィン・ディスカバリー・リミテッド | Hydroxam and carboxylic acid derivatives |
-
2003
- 2003-09-11 AU AU2003270625A patent/AU2003270625A1/en not_active Abandoned
- 2003-09-11 WO PCT/US2003/028751 patent/WO2004024089A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004024089A3 (en) | 2005-02-03 |
WO2004024089A2 (en) | 2004-03-25 |
AU2003270625A8 (en) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003224788A1 (en) | Method for treatment of tissue | |
AU2003290548A1 (en) | Prevention and treatment of synucleinopathic disease | |
AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
AU2003225766A1 (en) | Surgical coils and methods of deploying | |
EP1571969A3 (en) | Systems and methods for electrosurgical tissue treatment | |
AU2003276967A1 (en) | Microsurgical tissue treatment system | |
AU7434101A (en) | Treatment of bone diseases | |
AU2003270625A1 (en) | Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing | |
AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
AU2003260778A1 (en) | Treatment of pipes | |
AU2003217971A1 (en) | Gas-plasma treatment of implants | |
AU2003259833A1 (en) | Methods of treating neurodegenerative diseases | |
AU2003239184A1 (en) | Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides | |
AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2003256447A1 (en) | Treatment of autoimmune skin diseases | |
AU2003237076A1 (en) | Therapeutical use of anti-cd70 antibody for treating or preventing aids | |
AU2003263332A1 (en) | Wound dressings for the treatment of wound infection | |
AU2900100A (en) | Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss | |
AU2003222250A1 (en) | Treatment of autoimmune diseases | |
AU2003280688A1 (en) | Combination therapy of peptide vaccination and estramustine treatment | |
AU1405001A (en) | Treatment of diseases | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2003264954A1 (en) | Pharmaceutical composition for prevention and treatment of kidney diseases | |
AU2003297570A1 (en) | Treatment of skin diseases | |
AU2003272327A1 (en) | Methods of bone healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |